Clinical Trial Update: Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating intravenous immunoglobulin to prevent late cytomegalovirus disease in organ transplant recipients and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Camille N. Kotton, MD | Conditions: Cytomegalovirus, Organ Transplant | Phase 4 | Status: RECRUITING